Dupilumab and Growth Trends in Pediatric Atopic Dermatitis
Dupilumab-treated children showed higher bone alkaline phosphatase than placebo in atopic dermatitis trials, while four growth barriers inform urgent treatment.
Topic
Topic
Dupilumab-treated children showed higher bone alkaline phosphatase than placebo in atopic dermatitis trials, while four growth barriers inform urgent treatment.